Müller Cell Metabolic Signatures: Evolutionary Conservation and Disruption in Disease. (April 2020)

• Record Type: Journal Article
• Authors: Pfeiffer, Rebecca L.; Marc, Robert E.; Jones, Bryan W.
• Is Part Of: Trends in endocrinology and metabolism. Volume 31:Number 4(2020)
• Page Start: 320
• Page End: 329
• Publication Date: 2020-04
• Subjects: computational metabolic profiling -- retinal metabolism -- Müller cell -- glutamine synthetase -- retinal degeneration; Endocrinology -- Periodicals; Metabolism -- Periodicals; Metabolism; 616.4
• DOI: 10.1016/j.tem.2020.01.005
• Languages: English
• ISSNs: 1043-2760

Abstract

Abstract : Müller cells are glia that play important regulatory roles in retinal metabolism. These roles have been evolutionarily conserved across at least 300 million years. Müller cells have a tightly locked metabolic signature in the healthy retina, which rapidly degrades in response to insult and disease. This variation in metabolic signature occurs in a chaotic fashion, involving some central metabolic pathways. The cause of this divergence of Müller cells, from a single class with a unique metabolic signature to numerous separable metabolic classes, is currently unknown and illuminates potential alternative metabolic pathways that may be revealed in disease. Understanding the impacts of this heterogeneity on degenerate retinas and the implications for the metabolic support of surrounding neurons will be critical to long-term integration of retinal therapeutics for the restoration of visual perception following photoreceptor degeneration. Highlights: Müller cells are the primary macroglia of the retina, that have a highly conserved metabolic signature across species. During degeneration, Müller cells' metabolic signatures diverge and become chaotic. The glutamate cycle is disrupted during retinal degeneration, leading to levels of glutamate and glutamine varying irrespective of glutamine synthetase levels. Factors contributing to Müller cell metabolic homogeneity in health and heterogeneity in disease are currently matters of speculation requiring further investigation.